a Futurum companyLife Sciences companies aspire to harness AI models to expedite the development of treatments and therapies. However, fragmented data platforms often lack a strategic plan, leading to challenges like technical debt and difficulty identifying and reusing relevant data. Jenn Yarnold
Life Sciences companies aspire to harness AI models to expedite the development of treatments and therapies. However, fragmented data platforms often lack a strategic plan, leading to challenges like technical debt and difficulty identifying and reusing relevant data.
Reporting and analysis on the technology, teams and operating models behind modern software delivery.
